Associated Medical Conditions for Chronic Urticaria (Hives)

๐Ÿ“น Explaining this page and it's appropriate use.
The following is based on bacteria published studies. These are report on the averages of a group of patients; they do not apply to all patients and are not necessary predictive.

For some medical conditions there are hundreds of bacteria shifts reported, for others only a few. The Percentage is based on the least number. If there are matches 8 matches for a condition that has 10 known bacteria shifts, against a condition that has 50 bacteria shifts. It will be 8/10 or 80% and not 8/50= 16%. The count of possible bacteria is shown for reference.

Associations

Limited to conditions with 5 or more bacteria

Name Overlap Percent Prevalance in Population Matches Bacteria in From Bacteria in To
Allergies 30.4 % 30% 7 50 23
Alzheimer's disease 17.4 % 10% 4 50 23
Autism 39.1 % 2% 9 110 23
Ulcerative colitis 65.2 % 0.1% 15 108 23
Schizophrenia 26.1 % 0.75% 6 93 23
Ankylosing spondylitis 39.1 % 7% 9 520 23
Mood Disorders 16.7 % 29.7% 1 6 23
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 43.5 % 0.86% 10 134 23
Psoriasis 34.8 % 3% 8 46 23
Multiple Sclerosis 47.8 % 0.5% 11 100 23
Obesity 34.8 % 42.4% 8 104 23
Osteoporosis 18.2 % 9.4% 4 22 23
neuropsychiatric disorders (PANDAS, PANS) 13.3 % 0.1% 2 15 23
ME/CFS without IBS 13 % 0.4% 3 26 23
Obesity 17.4 % 42.4% 4 55 23
Metabolic Syndrome 14.3 % 21% 1 7 23
ME/CFS with IBS 21.1 % 2.8% 4 19 23
Liver Cirrhosis 47.8 % 0.27% 11 678 23
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 39.1 % 25% 9 76 23
Parkinson's Disease 17.4 % 1% 4 90 23
Systemic Lupus Erythematosus 39.1 % 0.15% 9 66 23
Depression 26.1 % 8% 6 81 23
Irritable Bowel Syndrome 30.4 % 15% 7 62 23
Insomnia 40 % 30% 4 10 23
Hyperlipidemia (High Blood Fats) 17.4 % 33% 4 25 23
hypercholesterolemia (High Cholesterol) 11.1 % 12% 1 9 23
hypertension (High Blood Pressure 16.7 % 47% 1 6 23
gallstone disease (gsd) 20 % 5% 3 15 23
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 13 % 27.8% 3 24 23
Fibromyalgia 13 % 1.12% 3 37 23
Functional constipation / chronic idiopathic constipation 17.4 % 14% 4 41 23
Epilepsy 21.7 % 0.84% 5 25 23
Cerebral Palsy 29.4 % 0.2% 5 17 23
Inflammatory Bowel Disease 56.5 % 1.3% 13 66 23
Type 1 Diabetes 21.7 % 0.19% 5 52 23
cystic fibrosis 14.3 % 0.03% 1 7 23
COVID-19 26.1 % 50% 6 36 23
Colorectal Cancer 26.1 % 4.3% 6 296 23
Celiac Disease 26.1 % 1.4% 6 67 23
Chronic Fatigue Syndrome 21.7 % 3% 5 55 23
Crohn's Disease 56.5 % 0.3% 13 141 23
Barrett esophagus cancer 12.5 % 7% 2 16 23
Bipolar Disorder 17.4 % 3% 4 33 23
Asthma 17.4 % 8% 4 27 23
Atherosclerosis 39.1 % 50% 9 524 23
Acne 15.8 % 47% 3 19 23
Small Intestinal Bacterial Overgrowth (SIBO) 12.5 % 52% 2 16 23
Generalized anxiety disorder 21.4 % 2.7% 3 14 23
Brain Trauma 13.6 % 0.367% 3 22 23
Sjögren syndrome 26.1 % 1.2% 6 41 23
Type 2 Diabetes 56.5 % 10.8% 13 267 23
Stress / posttraumatic stress disorder 21.7 % 5.2% 5 56 23
ADHD 17.4 % 9.4% 4 47 23
Hashimoto's thyroiditis 14.3 % 0.35% 2 14 23

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 ยงโ€ฏ1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.